StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$32.50−0.18 (-0.55%)

Close on Nov 17, 2026Market cap $152.14MP/E –Yield –

Korsana Biosciences total assets

Total assets on the balance sheet at the end of each period.

Korsana Biosciences's total assets was $6.93M at Jun 30, 2026. For fiscal 2025 it was $9.99M, up 4.3% from the year before. The highest annual figure on record is $186.48M in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.99M+4.3%
FY2024Dec 31, 2024$9.58M-28.4%
FY2023Dec 31, 2023$13.37M-26.0%
FY2022Dec 31, 2022$18.08M-69.5%
FY2021Dec 31, 2021$59.33M-48.6%
FY2020Dec 31, 2020$115.38M-38.1%
FY2019Dec 31, 2019$186.48M+2419.6%
FY2018Dec 31, 2018$7.40M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.93M-26.0%
Q1 FY2026Mar 31, 2026$8.51M-13.6%
Q4 FY2025Dec 31, 2025$9.99M+4.3%
Q3 FY2025Sep 30, 2025$10.42M+17.0%
Q2 FY2025Jun 30, 2025$9.37M-6.9%
Q1 FY2025Mar 31, 2025$9.85M-13.3%
Q4 FY2024Dec 31, 2024$9.58M-28.4%
Q3 FY2024Sep 30, 2024$8.90M-41.5%
Q2 FY2024Jun 30, 2024$10.07M-0.3%
Q1 FY2024Mar 31, 2024$11.36M-0.8%
Q4 FY2023Dec 31, 2023$13.37M-26.0%
Q3 FY2023Sep 30, 2023$15.21M-39.3%
Q2 FY2023Jun 30, 2023$10.10M-71.3%
Q1 FY2023Mar 31, 2023$11.46M-75.4%
Q4 FY2022Dec 31, 2022$18.08M-69.5%
Q3 FY2022Sep 30, 2022$25.05M-63.0%
Q2 FY2022Jun 30, 2022$35.21M-53.5%
Q1 FY2022Mar 31, 2022$46.53M-53.5%
Q4 FY2021Dec 31, 2021$59.33M-48.6%
Q3 FY2021Sep 30, 2021$67.74M-48.4%
Q2 FY2021Jun 30, 2021$75.73M-40.9%
Q1 FY2021Mar 31, 2021$99.97M-28.6%
Q4 FY2020Dec 31, 2020$115.38M-38.1%
Q3 FY2020Sep 30, 2020$131.40M-37.3%
Q2 FY2020Jun 30, 2020$128.04M-45.6%
Q1 FY2020Mar 31, 2020$140.03M+1332.8%
Q4 FY2019Dec 31, 2019$186.48M+2419.6%
Q3 FY2019Sep 30, 2019$209.70M–
Q2 FY2019Jun 30, 2019$235.50M–
Q1 FY2019Mar 31, 2019$9.77M–
Q4 FY2018Dec 31, 2018$7.40M–

More Korsana Biosciences figures

See a number that looks wrong?